COLLABORATIVE ARRANGEMENTS (Tables)

12 Months Ended

Dec. 31, 2016

COLLABORATIVE ARRANGEMENTS

Schedule of net revenue recognized under GSK Agreements

	Year Ended December 31,
(In thousands)	2016			2015			2014
Royalties from a related party — RELVAR/BREO	$	128,638		$	59,188		$	16,635
Royalties from a related party — ANORO		17,869			7,699			1,782
Total royalties from a related party		146,507			66,887			18,417
Less: amortization of capitalized fees paid to a related party		(13,823	)		(13,823	)		(11,066	)
Royalty revenue		132,684			53,064			7,351
Strategic alliance — MABA program license		885			885			1,082
Total net revenue from GSK	$	133,569		$	53,949		$	8,433